Literature DB >> 19656475

Basophil responsiveness in chronic urticaria.

Sarbjit S Saini1.   

Abstract

Chronic urticaria is a common skin disease without an etiology in the majority of cases. The similarity of symptoms and pathology to allergen-induced skin reactions supports the idea that skin mast cell and blood basophil IgE receptor activation is involved; however, no exogenous allergen trigger has been identified. Recent evidence supports a role for blood basophils in disease expression. Specifically, blood basopenia is noted in active disease with the recruitment of blood basophils to skin lesional sites. In addition, blood basophils display altered IgE receptor-mediated degranulation that reverts in disease remission. In active chronic idiopathic urticaria (CIU) subjects, changes in IgE receptor-signaling molecule expression levels accompany the altered degranulation function in blood basophils. The arrival of therapies targeting IgE has further shown that altered blood basophil degranulation behavior has potential use as a disease biomarker in CIU.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656475      PMCID: PMC6452217          DOI: 10.1007/s11882-009-0040-3

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  45 in total

1.  Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission.

Authors:  P Jacques; A Lavoie; P M Bédard; C Brunet; J Hébert
Journal:  J Allergy Clin Immunol       Date:  1992-06       Impact factor: 10.793

Review 2.  Newly discovered roles for basophils: a neglected minority gains new respect.

Authors:  Hajime Karasuyama; Kaori Mukai; Yusuke Tsujimura; Kazushige Obata
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

3.  The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor.

Authors:  T Kimura; H Sakamoto; E Appella; R P Siraganian
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

4.  Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity.

Authors:  C E Grattan; D Walpole; D M Francis; N Niimi; G Dootson; S Edler; M F Corbett; R M Barr
Journal:  Clin Exp Allergy       Date:  1997-12       Impact factor: 5.018

5.  Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.

Authors:  E N Charlesworth; A Kagey-Sobotka; R P Schleimer; P S Norman; L M Lichtenstein
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

6.  Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies.

Authors:  John A Eckman; Robert G Hamilton; Laura M Gober; Patricia M Sterba; Sarbjit S Saini
Journal:  J Invest Dermatol       Date:  2008-03-20       Impact factor: 8.551

Review 7.  Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.

Authors:  Stephanie J Harris; Richard V Parry; John Westwick; Stephen G Ward
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

8.  Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.

Authors:  R A Sabroe; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Allergy Clin Immunol       Date:  1998-10       Impact factor: 10.793

Review 9.  Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1.

Authors:  Matt Morgan; David A Khan
Journal:  Ann Allergy Asthma Immunol       Date:  2008-05       Impact factor: 6.347

Review 10.  New insights into the roles for basophils in acute and chronic allergy.

Authors:  Kaori Mukai; Kazushige Obata; Yusuke Tsujimura; Hajime Karasuyama
Journal:  Allergol Int       Date:  2009-01-25       Impact factor: 5.836

View more
  13 in total

Review 1.  New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation.

Authors:  Mark C Siracusa; Michael R Comeau; David Artis
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 3.  The itchy scalp--scratching for an explanation.

Authors:  Ghada A Bin Saif; Marna E Ericson; Gil Yosipovitch
Journal:  Exp Dermatol       Date:  2011-12       Impact factor: 3.960

Review 4.  Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.

Authors:  Katherine Altman; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

Review 5.  Aeroallergens in Atopic Dermatitis and Chronic Urticaria.

Authors:  Albert C Chong; Won Jong Chwa; Peck Y Ong
Journal:  Curr Allergy Asthma Rep       Date:  2022-04-01       Impact factor: 4.806

Review 6.  Urticaria.

Authors:  Pavel Kolkhir; Ana M Giménez-Arnau; Kanokvalai Kulthanan; Jonny Peter; Martin Metz; Marcus Maurer
Journal:  Nat Rev Dis Primers       Date:  2022-09-15       Impact factor: 65.038

Review 7.  Basophils and skin disorders.

Authors:  Francesco Borriello; Francescopaolo Granata; Gianni Marone
Journal:  J Invest Dermatol       Date:  2014-02-06       Impact factor: 8.551

8.  The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.

Authors:  Kirti J Johal; Kristin L Chichester; Eric T Oliver; Kelly C Devine; Anja P Bieneman; John T Schroeder; Donald W MacGlashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 14.290

Review 9.  Looking forward to new targeted treatments for chronic spontaneous urticaria.

Authors:  Emek Kocatürk; Marcus Maurer; Martin Metz; Clive Grattan
Journal:  Clin Transl Allergy       Date:  2017-01-10       Impact factor: 5.871

10.  Immunomodulation Effects of Schizonepeta tenuifolia Briq. on the IgE-Induced Allergic Model of RBL-2H3 Cells.

Authors:  Yi-Hsuan Lin; Hsing-Yu Chen; Jung-Chun Chiu; Kun-Jei Chen; Hung-Yao Ho; Sien-Hung Yang
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.